- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/04 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 205/04
Total number of patents in this class: 1296
10-year publication summary
|
82
|
85
|
78
|
92
|
86
|
95
|
93
|
71
|
71
|
27
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10346 |
40 |
| Bristol-myers Squibb Company | 4812 |
22 |
| Takeda Pharmaceutical Company Limited | 2718 |
22 |
| Incyte Corporation | 1059 |
20 |
| Janssen Pharmaceutica N.V. | 3233 |
19 |
| F. Hoffmann-La Roche AG | 7835 |
17 |
| Ono Pharmaceutical Co., Ltd. | 419 |
15 |
| Genentech, Inc. | 4065 |
13 |
| Boehringer Ingelheim International GmbH | 4529 |
13 |
| Abbvie Inc. | 1843 |
13 |
| Allergan, Inc. | 2214 |
12 |
| Epicentrx, Inc. | 84 |
12 |
| Autobahn Therapeutics, Inc. | 42 |
12 |
| Corteva Agriscience LLC | 2636 |
12 |
| AstraZeneca AB | 2836 |
11 |
| Araxes Pharma LLC | 92 |
11 |
| Biogen MA Inc. | 926 |
11 |
| Incyte Holdings Corporation | 637 |
11 |
| Integrative Research Laboratories Sweden AB | 38 |
11 |
| Northrop Grumman Systems Corporation | 2931 |
10 |
| Other owners | 989 |